We are live on ! Find out more
NVIV

InVivo Therapeutics Holdings Corp
NVIV

Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

38 hedge funds and large institutions have $39.5M invested in InVivo Therapeutics Holdings Corp in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 3

65% more call options, than puts

Call options by funds: $3.91M | Put options by funds: $2.36M

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

3% more funds holding

Funds holding: 37 → 38 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10% less capital invested

Capital invested by funds: $43.9M → $39.5M (-$4.44M)

Holders
38
Holders Change
+1
Holders Change %
+2.7%
% of All Funds
1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
10
Reduced
3
Closed
5
Calls
$3.91M
Puts
$2.36M
Net Calls
+$1.55M
Net Calls Change
-$2.31M

Top Buyers

Rank Fund Capital Flow
1
WF
Welch & Forbes
Massachusetts
+$1.04M
2
BIT
BlackRock Institutional Trust
California
+$743K
3
Goldman Sachs
Goldman Sachs
New York
+$446K
4
Group One Trading
Group One Trading
Illinois
+$446K
5
EIM
Emerson Investment Management
Massachusetts
+$297K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$594K
2
Citigroup
Citigroup
New York
-$297K
3
TCIM
TIAA CREF Investment Management
New York
-$297K
4
Millennium Management
Millennium Management
New York
-$173K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$149K
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
26
New York State Common Retirement Fund
New York
$174K – – –
MLICM
27
Metropolitan Life Insurance Company (MetLife)
New York
$151K – – –
State Board of Administration of Florida Retirement System
28
State Board of Administration of Florida Retirement System
Florida
$138K – – –
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$134K -$594K -4 -80%
NFA
30
Nationwide Fund Advisors
Ohio
$123K – – –
AIG
31
American International Group
New York
$122K – – –
VOYA Investment Management
32
VOYA Investment Management
Georgia
$105K – – –
QI
33
QS Investors
New York
$92K +$149K +1 New
HKIM
34
Hayek Kallen Investment Management
Alabama
$79K – – –
Cambridge Investment Research Advisors
35
Cambridge Investment Research Advisors
Iowa
$76K – – –
YP
36
Yellowstone Partners
Idaho
$72K +$149K +1 New
Bank of America
37
Bank of America
North Carolina
$68K +$149K +1 New
BA
38
BlackRock Advisors
Delaware
$59K -$149K -1 Closed
AFP
39
Ausdal Financial Partners
Iowa
$56K – – –
Wells Fargo
40
Wells Fargo
California
$56K – – –
Deutsche Bank
41
Deutsche Bank
Germany
$46K – – –
BNP Paribas Financial Markets
42
BNP Paribas Financial Markets
France
$38.3K – – –
LTFS
43
Ladenburg Thalmann Financial Services
Florida
$35K – – –
Creative Planning
44
Creative Planning
Kansas
$32K – – –
IA
45
IFP Advisors
Florida
$18K – – –
Simplex Trading
46
Simplex Trading
Illinois
$9K – – –
BlackRock
47
BlackRock
New York
$5K – – –
TRCT
48
Tower Research Capital (TRC)
New York
$5K – – –
Citigroup
49
Citigroup
New York
$4K -$297K -2 Closed
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$4K – – –
1
2
3

NVIV Hedge Fund Activity: Q4 2015 in Review

38 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q4 2015, worth a combined $39.5M — down 10% from $43.9M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NVIV positions and 5 closed out — a net gain of 1 holder — while 10 added to existing stakes and 3 trimmed.

The largest buyer was Welch & Forbes, adding an estimated $1.04M. The largest seller was Susquehanna International Group, cutting an estimated $594K.

  • 38 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q4 2015, up from 37 in Q3 2015.
  • Funds reported $39.5M of InVivo Therapeutics Holdings Corp stock for Q4 2015, down 10% quarter-over-quarter.
  • 6 funds opened new InVivo Therapeutics Holdings Corp positions in Q4 2015 and 5 closed out, a net change of +1 holder.
  • The largest InVivo Therapeutics Holdings Corp buyer in Q4 2015 was Welch & Forbes, an estimated $1.04M added.
  • The largest InVivo Therapeutics Holdings Corp seller in Q4 2015 was Susquehanna International Group, an estimated $594K sold.

Based on aggregated 13F filings for Q4 2015.